Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Shares Issued: 2020-2024

Historic Shares Issued for Taysha Gene Therapies (TSHA) over the last 4 years, with Dec 2024 value amounting to $89,000.

  • Taysha Gene Therapies' Shares Issued rose 93.65% to $122,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $286,000, marking a year-over-year decrease of 51.44%. This contributed to the annual value of $89,000 for FY2024, which is 82.20% down from last year.
  • As of FY2024, Taysha Gene Therapies' Shares Issued stood at $89,000, which was down 82.20% from $500,000 recorded in FY2023.
  • In the past 5 years, Taysha Gene Therapies' Shares Issued ranged from a high of $165.9 million in FY2020 and a low of $89,000 during FY2024.
  • Its 3-year average for Shares Issued is $280,667, with a median of $253,000 in 2022.
  • Per our database at Business Quant, Taysha Gene Therapies' Shares Issued soared by 97.63% in 2023 and then crashed by 82.20% in 2024.
  • Taysha Gene Therapies' Shares Issued (Yearly) stood at $165.9 million in 2020, then reached $253,000 in 2022, then soared by 97.63% to $500,000 in 2023, then crashed by 82.20% to $89,000 in 2024.